Baxter International (BAX) Net Income towards Common Stockholders (2009 - 2026)

Baxter International's (BAX) quarterly Net Income towards Common Stockholders came in at $2.0 million in Q1 2026, down 96.77% year-on-year from $62.0 million in Q1 2025, and up 102.15% on a QoQ basis from -$93.0 million in Q4 2025.

Baxter International (BAX) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Baxter International (BAX) has 18 years of Net Income towards Common Stockholders data on file, last reported at $2.0 million in Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 96.77% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was -$117.0 million, a 58.66% increase from a year earlier, with the FY2025 full-year figure at -$57.0 million, up 81.73% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at $2.0 million, up from -$93.0 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for BAX reached as high as $2.5 billion in Q3 2023 and fell as low as -$406.0 million in Q2 2024.
  • Historically, Net Income towards Common Stockholders has averaged $138.1 million across 5 years, with a median of $33.0 million in 2024.
  • Across the five-year window, Net Income towards Common Stockholders jumped 4240.35% in 2023 and slumped 322.73% in 2025, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at $41.0 million in 2022, then plunged by 34.15% to $27.0 million in 2023, then slumped by 181.48% to -$22.0 million in 2024, then tumbled by 322.73% to -$93.0 million in 2025, then surged by 102.15% to $2.0 million in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $2.0 million in Q1 2026, -$93.0 million in Q4 2025, and $5.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 126.32 Bn 121.10 Bn 1.96 Bn 823.20 Mn
2 Becton Dickinson 44.69 Bn 43.88 Bn 2.15 Bn -274.00 Mn
3 Alcon 32.80 Bn 31.14 Bn 1.53 Bn 22.13 Bn
4 Medline 32.72 Bn 30.49 Bn 1.84 Bn 239.00 Mn
5 Resmed 29.54 Bn 27.88 Bn 890.98 Mn 398.73 Mn
6 West Pharmaceutical Services 23.56 Bn 23.13 Bn 329.20 Mn 147.90 Mn
7 Solventum 14.00 Bn 13.44 Bn 1.10 Bn 13.00 Mn
8 Cooper Companies 13.75 Bn 13.61 Bn 735.40 Mn -77.90 Mn
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn 112.77 Mn
10 Baxter International 12.00 Bn 9.98 Bn 891.00 Mn 2.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.00 Mn
Dec 31, 2025 -93.00 Mn
Sep 30, 2025 5.00 Mn
Jun 30, 2025 -31.00 Mn
Mar 31, 2025 62.00 Mn
Dec 31, 2024 -22.00 Mn
Sep 30, 2024 83.00 Mn
Jun 30, 2024 -406.00 Mn
Mar 31, 2024 33.00 Mn
Dec 31, 2023 27.00 Mn
Sep 30, 2023 2.47 Bn
Jun 30, 2023 -112.00 Mn
Mar 31, 2023 93.00 Mn
Dec 31, 2022 41.00 Mn
Sep 30, 2022 57.00 Mn
Jun 30, 2022 70.00 Mn
Mar 31, 2022 65.00 Mn
Dec 31, 2021 -20.00 Mn
Sep 30, 2021 452.00 Mn
Jun 30, 2021 301.00 Mn